CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 87 filers reported holding CTI BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $60,000 | -56.8% | 112,900 | 0.0% | 0.00% | – |
| Q4 2015 | $139,000 | +0.7% | 112,900 | +19.9% | 0.00% | – |
| Q3 2015 | $138,000 | -25.0% | 94,200 | 0.0% | 0.00% | – |
| Q2 2015 | $184,000 | +7.6% | 94,200 | 0.0% | 0.00% | – |
| Q1 2015 | $171,000 | -23.0% | 94,200 | 0.0% | 0.00% | – |
| Q4 2014 | $222,000 | -2.6% | 94,200 | 0.0% | 0.00% | – |
| Q3 2014 | $228,000 | +83.9% | 94,200 | +114.1% | 0.00% | – |
| Q2 2014 | $124,000 | – | 44,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 44,796,940 | $23,805,000 | 5.89% |
| Stonepine Capital Management, LLC | 3,743,340 | $1,989,000 | 2.35% |
| Bayesian Capital Management, LP | 76,100 | $40,000 | 0.04% |
| JW Asset Management, LLC | 50,254 | $27,000 | 0.02% |
| WASHINGTON TRUST Co | 410,616 | $218,000 | 0.02% |
| Modera Wealth Management, LLC | 25,000 | $13,000 | 0.01% |
| Alyeska Investment Group, L.P. | 773,469 | $411,000 | 0.00% |
| First Heartland Consultants, Inc. | 14,924 | $8,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $279,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 188,500 | $100,000 | 0.00% |